Several multivariable risk prediction models have been developed to asses an individual's risk of developing specific cancers. Such models can be used in a variety of settings for prevention, screening and guiding investigations and treatments. Models aimed at predicting future disease risk that contains lifestyle factors may be of particular use for targeting health promotion activities at an individual level. This type of cancer risk prediction is not yet available in the UK. We have adopted the approach used by the well-established U.S. derived "YourCancerRisk" model for use in the UK population which allow users to quantify their individual risk of developing individual cancers relative to the population average risk. The UK version of YourCancerRisk" computes 10 year cancer risk estimates for 11 cancers utilising UK figures for prevalence of risk factors and cancer incidence. Since the prevalence of risk factors and the incidence rates for cancer are different between the US and the UK population, this UK model provides more accurate estimates of risks for a UK population. Using an example of breast cancer and data from UK Biobank cohort we demonstrate that the individual risk factor estimates are similar for the US and UK populations. Assessment of the performance and validation of the multivariate model predictions based on a binary score confirm the model's applicability. The model can be used to estimate absolute and relative cancer risk for use in Primary Care and community settings and is being used in the community to guide lifestyle change.
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Introduction.
Over recent years, there has been a growth in the development of risk prediction models for cancer and other diseases (1) (2) (3) (4) (5) (6) . These models provide a range of estimates of future risk of developing disease for applications in prevention, screening, diagnosis and treatment. Most of them are disease specific. In general, risk algorithms include phenotypic information such as sex, age, and lifestyle factors. Some algorithms may also allow for the incorporation of emerging "omics" based factors and other biomarkers (7) .
Few cancer risk prediction models have included the modifiable risk components such as physical activity, diet and smoking. One such model that has been developed for the US is the "YourCancerRisk" model which has been used as a tool for education as well as providing an approach to quantifying the effects of changing key lifestyle exposures.
This was subsequently expanded into "YourDiseaseRisk" (8) which extends the range of endpoints to include 12 of the commonest types of cancers in the USA and 6 other chronic diseases (e.g., chronic bronchitis, stroke, emphysema, heart disease, diabetes, and osteoporosis). The model was validated for ovarian, colon and pancreatic cancers in the U.S in Nurses' Health Study and the US Health Professionals cohorts. The results show the model to be well calibrated for ovarian and colon cancer in women and pancreatic cancer in men and moderately calibrated for colon cancer in men.
Discriminatory accuracy for pancreatic cancer showed a concordance index of 0.72, and for colon cancer in men and women concordance indices were 0.71, 0.67 respectively) (9).
Cancer Research. The "YourDiseaseRisk" model aims to predict the risks for individuals (aged 40 and above) of developing the 12 cancers relative to the general population. Uniquely, the approach adopted to develop such models involved extensive systematic reviews of existing studies and finding a consensus of expert opinions to identify risk factors and to the summarise the level of evidence as "definite", "probable" and "possible" causes of cancer. Risk points were then allocated according to the strength of the causal association and summed. Population average risk of cancer and cumulative 10-year risk were obtained from the US SEER data (10). Finally, individual ranking relative to the population average was determined. The focus of this paper is to describe the steps taken to adapt the "YourDiseaseRisk" models focused on cancers for the UK population for use in Primary Care and community based settings. We also assess the utility of the approach by scoring the suggested risk factors in the UK Biobank cohort.
We have used the adapted UK version of the "YourDiseaseRisk" models (8) in a pilot study that used individual interviews to assess participants' understanding and preferences for how such information is offered (publication in press). These results will be presented elsewhere. We adapted the YourDiseaseRisk models for 11 cancers using the UK data. The 11 cancers chosen were lung, prostate, breast, kidney, bladder, colon, skin, stomach, pancreatic, uterine and ovarian cancer. Cervical cancer was not included as it required participants to disclose information on sexual history which was considered too sensitive.
In general terms, the information required to develop prediction models are: 1) the identified list of risk factors for inclusion; 2) point estimates of the relative risk for each risk factor; and 3) population prevalence for each of the exposures. To be able to compare individual risk to the population, further information such as cancer incidence by 10 year age bands is required.
Comparison of relative risk (RR) between the US and the UK.
To illustrate the comparative RRs between the two populations, we used the UKBiobank national cohort and analysed the RRs for breast cancer. The UKBiobank female cohort consists of 273,467 women with age ranged between 40-69 years when recruited.
Participants were enrolled in the UK Biobank from April, 2007, to July, 2010, from 21 assessment centres across England, Wales, and Scotland using standardised procedures (11) . The UK Biobank study was approved by the North West Multi-Centre
Research Ethics Committee and all participants provided written informed consent to participate in the UK Biobank study. To date, the cohort has been followed up for 6 years. We computed RRs adjusted only for age. The results are presented in The total number of incident breast cancer cases was 3,378 and the total number of non-cancer controls was 235,603 or healthy controls was 59,731. We coded all variables (except Tamoxifen/Raloxifene usage as such data was not available) present in the breast cancer risk prediction model based on presence or absence of the exposure for each individual as illustrated in Table 3 . To demonstrate the validity of the combined risk factors identified for the model we calculated the area under the curve of the model based on including all factors scored as a binary variable and generated calibration plots -the observed and expected proportions compare within the groups formed by the Hosmer-Lemeshow test. All analyses were performed using STATA 14 (12) .
Results.
To develop the UK version of the "YourDiseaseRisk" models we have assumed that the risk factors for these cancers in the US and UK are the same and have obtained the list of risk factors and point estimates of relative risk for each risk factor from the US "YourDiseaseRisk" models. Since the "YourDiseaseRisk" model was first developed more than a decade ago and to ensure we use the most updated version, we started the process by extracting risk factors for each cancer from the "YourDiseaseRisk" online version(8) ( Step 1). Once we created a list of risk factors for each cancer, we assigned point estimates of relative risk (RR) for each factor (Step 2). These point estimates of RR's were extracted from the original publication (13, 14) , however if any factors did not have any cited value, we performed a literature search to obtain any missing estimates. To maintain consistency across RR values, we used figures from publications by the Colditz study group and those with a cohort study design (examples of references are depicted in Table 1 ). For example, as the multivitamin factor was not listed in the original article, we therefore chose and applied a RR of 0.7 from Zhang et al (15) .
As the original report applied RRs from compiling evidence from the US cohort studies over a period of time, it is important to justify the use of the RRs published by Colditz et al (14) in the UK models. We demonstrated the similarities/variations of risks between the two populations (US and UK). To do this we have presented as an example the relative risks for breast cancer derived from the UKBiobank study (Table 2 ). The majority of the point estimates are similar and convert to the same risk score when using values in Table3. The two exceptions were for multivitamin use and physical activity where the protective effects for both of these factors were less pronounced in the UK as compared to the US estimate.
To obtain the population prevalence (step 3) for each of the exposures we then reviewed the literature on the UK prevalence of each factor for men and women for all Table 1 .
Computing risk scores.
Once information on the UK prevalence of each risk factor was obtained, we then applied a score to each risk factor using the same scheme as presented in the original paper (summary as shown in Table 3 ).
This risk score is used to compute two further scores -the population average risk score and an individual risk score relative to the population average. The population average score is calculated by multiplying the risk score of each factor by the population prevalence of that particular factor. To prevent negative scores, we chose the direction of each risk factor to make the population average score the highest possible. Taking physical activity, for example, the prevalence of carrying out 3 or more hours of total leisure-time physical activity per week in the UK population is 23%. This figure means that 77% of the population do not do physical activity regularly at this particular level.
When we apply a prevalence of 77% then the assigned score instead of being -10 (for those who are doing regular exercise) will be +10. This conversion allows us to demonstrate the change in the individual risk score following any change in factors that are modifiable. Summation of these scores produces the average population score.
The risk score for a given individual relative to the population average is based on presence or absence of each factor. An example is illustrated in Table 4 . The summation of scores for each risk factor for an individual provides the total risk score for a particular person That total risk score is then divided by the average population score to give an individual index which is relative to population score (35/27= 1. Table 4 can be reduced by 10 points (from 35 to 25), making their index score relative to the population reduced from 1.3 to 0.8. This calculation aims to illustrate to each individual the effect of a particular lifestyle or behaviour change leading to cancer risk reduction.
Conversion of individual index score to 5-category cancer level of risk.
The index score for an individual can then be further transformed into a level of risk. A numeric factor indicative of the strength of the risk level is assigned to the individual index score (Table 5 ). This is done to give an average value of the range of individual index scores as a single numeric estimate that reflects the risk level.
For the individual in Table 3 , for example, the individual index score is 1.3, which is equivalent to "above average risk" and gives a numeric factor of 1.5.
Year estimated cancer risk.
To enable estimation of an individual's 10 year estimated cancer risk we calculated the average 10 year estimated risk for different ages and sexes of the UK population for all 11 cancers. We used the "Current Probability" method proposed by Esteve et al in 1994 (17) . This method uses a life-table approach for calculating the risk of developing cancer, and takes into account the likelihood of dying from other causes. The method also requires information on deaths from all causes for each age-group. This method provides estimate of the 10 year risk of cancer.
We obtained age-and sex-specific cancer incidence and mortality rates and numbers from Cancer Research UK (18) and age-and sex-specific data on all-cause mortality From this data we computed 10-year cancer risk for each cancer in males and females in 10 year age bands from birth to over 80 years.
Individual estimate 10 year cancer risk. Table 4 is a 40-year-old woman, the average 10-year risk of breast cancer (age 40-49) is 1.45% in the next 10 years (Table 6 ). Multiplying this figure by the numeric factor of 1.5 (Table 4) 
Assuming the individual in
comparison group of controls with no cancer or other illnesses. Model calibration curves for both comparisons also suggested both models calibrated well (Figure 1 ).
Discussion.
The "YourDiseaseRisk" model has been developed using three key data including an estimate of relative risk of each risk factor, the prevalence figure of exposure in the population and the 10 year estimated cancer risk. These figures can be acquired through literature review, National data archives or other organisations that compile these data publically (20).
The "YourDiseaseRisk" site has been launched since 2000 and update/review of information is an ongoing process. The model is an educational tool and can be used for cancer prevention in clinics, community settings, or by individuals simply seeking information on their own. The popularity of "YourDiseaseRisk" is reflected by the large number of hits or page views.
We have adopted their methodology and applied it to build a UK version and to demonstrate the applicability of the approach for other populations as well. The main strengthen of the approach is the use of large population based studies to estimate the parameters needed to generate the model.
To demonstrate the relative validity of the approach we chose breast cancer as an exemplar. We have demonstrated that the quantitative estimates of the individual risk factors apply to current UK population using data from the UKBiobank study. There are, however, potential limitations to the approach that need to be taken into consideration. Firstly, although we were systematic in our literature reviews to obtain data on the point estimate RRs for risk factors missing from the original published "YourDiseaseRisk" model and the prevalence of all risk factors in the UK population, the studies we have chosen may not provide the most accurate estimates. Secondly, we have assumed that the prevalence of each risk factor does not change with age, that the risk associated with each risk factor is the same across all ages and both sexes, and that the risk factors do not interact with each other. These assumptions were also made in the development of the "YourDiseaseRisk" models but, as noted in that report (14) , may result in misclassification of risk for exposures across large age ranges and underestimate possible synergistic effects of exposures such as alcohol and smoking. As for the "YourDiseaseRisk" models, therefore, these models should be considered as a guide for assessing an individual's risk of cancer in the UK rather than a precise estimate.
Risk prediction models are widely used for many diseases. With the concept that some cancers can be preventable, the "Your Disease risk" model developed by Colditz et al (14) provides a good platform because their model is based on modifiable factors that have been scrutinised and carefully selected by a panel of experts. The approach has wide utility in allowing for the rapid development of models for educational purposes.
In this paper we have described how we have adapted that model to produce a UK version for 11 cancers using data from the UK population. We are now using the model in the community in the UK. Going forwards we will evaluate how the tool affects perceptions of risk, how to best present the risk, and how the public understands their individual risk. This information will then inform future studies in the community exploring the potential for the use of this model to promote lifestyle change. Finally, we will extend and further validate this risk prediction in the UKBiobank cohort as more precise individual level data and longer term follow up data become available. 0.9 to < 1.1 0 0.7 to < 0.9 or 1.1 to < 1. 
